Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

Shelley Wood

December 28, 2017

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

Presentation TCT 2017

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Samir R. Kapadia, David J. Moliterno

November 01, 2017

Presentation TCT 2017

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Samir R. Kapadia, Sameer Gafoor

November 01, 2017

Presentation TCT 2017

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Presenter: Samir R. Kapadia, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Presenter: Samir R. Kapadia, Ashish Pershad

November 01, 2017

Presentation TCT 2017

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

November 01, 2017

Presentation TCT 2017

CASE 1 - TAVR Complicated by LM Occlusion and Salvaged by PCI

Presenter: Pedro de Araujo Goncalves, Mirvat Alasnag

October 30, 2017

Presentation TCT 2017

A Case of TAVR, Left Main PCI and Permanent Pacemaker Implantation in a Nonagenarian

Presenter: Wojtek Wojakowski, Gautam Naik

October 30, 2017

Presentation TCT 2017

Impella and Rotablation-assisted Bifurcation PCI Following Previous Edwards SAPIEN 3 TAVR

Presenter: Mohamed Ahmed Sobhy, Faisal Khan

October 30, 2017

Presentation TCT 2017

Keynote Lecture. European Commission: Evolving Impact of Device Regulation in Europe

Presenter: Gregg W. Stone, Bram D. Zuckerman, Alan G. Fraser

October 30, 2017

Presentation TCT 2017

Keynote Lecture - FDA/CDRH: Evolving Impact of Device Regulation in the US

Presenter: Gregg W. Stone, Bram D. Zuckerman, William H. Maisel

October 30, 2017

Presentation TCT 2017

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Industry Perspectives

Presenter: Gregg W. Stone, Bram D. Zuckerman, Richard E. Kuntz

October 30, 2017

Presentation TCT 2017

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Physician-Scientist Perspectives

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 30, 2017

Presentation TCT 2017

Clinical Case #2: A TAVR Procedure You Dont See Everyday

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Daniel H. Berrocal

October 29, 2017

Presentation TCT 2017

Fifteen Years After the First TAVR, Where Are We and Where Are We Headed?

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Martin B. Leon

October 29, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

Podcast

Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients

October 11, 2017

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2017

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

CASE 1 - TAVR Complicated by LM Occlusion and Salvaged by PCI

A Case of TAVR, Left Main PCI and Permanent Pacemaker Implantation in a Nonagenarian

Impella and Rotablation-assisted Bifurcation PCI Following Previous Edwards SAPIEN 3 TAVR

Keynote Lecture. European Commission: Evolving Impact of Device Regulation in Europe

Keynote Lecture - FDA/CDRH: Evolving Impact of Device Regulation in the US

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Industry Perspectives

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Physician-Scientist Perspectives

Clinical Case #2: A TAVR Procedure You Dont See Everyday

Fifteen Years After the First TAVR, Where Are We and Where Are We Headed?

TCTMD’s Top 10 Most Popular Stories for October 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content